Enquiring About Tolerance (EAT) Study. Randomised controlled trial of early introduction of allergenic foods to induce tolerance in infants
|
|
- Darren Adams
- 5 years ago
- Views:
Transcription
1 Enquiring About Tolerance (EAT) Study Randomised controlled trial of early introduction of allergenic foods to induce tolerance in infants Final version 20/08/2012 STATISTICAL ANALYSIS PLAN FOR MAIN PAPER This document has been edited by Janet Peacock with substantial input from Salma Ayis, Michael Perkin, Kirsty Logan, and Gideon Lack. This version has been reviewed and approved by the EAT study steering committee. The document is designed to provide a record of and guide to all pre-planned analyses that will be included in the first and main outcome paper of the EAT study. It is not intended to include the additional analyses that may be performed, either as pre-planned or as a result of hypotheses generated by the primary analyses and that will go in subsequent publications. These will be covered in a separate document. 1. TRIAL DESIGN: This is a randomized controlled trial of the early introduction of allergenic foods (and other foods) from three months of age in the general population with target accrual of 1302 participants. Mothers were recruited initially antenatally from two large antenatal units (Kingston and St Thomas Hospitals) (antenatal recruitment ceased November 2009) and subsequently postnatally using invitations mailed to parents who are members of the Bounty Parenting Club. All infants will be followed up until three years of age by which point the impact of the intervention on the primary outcome (food allergy) and secondary outcomes - asthma (including atopic wheeze), eczema, allergic rhinitis (including aero-allergen sensitization), combined food allergy prevalence (including food sensitization) and the prevalence of combined allergic disease will be known. As described in the EAT Protocol, Figure 5, Overall Study Design 2. TRIAL OBJECTIVES: To determine whether early introduction of allergenic foods (from three months of age) reduces the prevalence of food allergy (FA), eczema, asthma and allergic rhinitis (AR) by three years of age. This study will provide an informed basis for future infant feeding practices in both atopic and normal infants. 3. TRIAL ARMS 3.1 Early introduction group: Dietetic controlled introduction of allergenic foods from three months of age. A pureed fruit / vegetable or baby rice mixed with breast milk or water commenced first, followed by cow s milk based yoghurt. Subsequently egg, sesame, fish, and peanut introduced in a randomized order, with wheat introduced last. (For further details on ingestion timing and quantities for each food, see protocol). 3.2 Standard introduction group: Standard introduction following current UK Government infant feeding advice (exclusive breastfeeding until around 26 weeks of age) and avoid introducing foods that may cause allergies before six months of age (cow s milk, egg, wheat, peanuts, tree nuts, seeds, fish and shell fish). 4.0 SAMPLE SIZE AND POWER The trial has 80% power to detect a 50% relative reduction in the absolute prevalence (from 8% in the standard introduction arm to 4% in the intervention arm) of food allergy by three years of age, assuming a 15% 1
2 drop out rate. These numbers were used to calculate the final cohort size of 1302 infants (651 infants in each arm) yielding a final cohort size of 1106 infants (553 infants in each arm) after drop out (based on the amended protocol September 2010). The whole cohort is to be followed up until the primary assessment point at three years of age. The study is also designed so that it has sufficient power to detect a protective effect in the high risk subpopulation. The high risk children are defined as being the 25% with eczema present at three months of age, who have an estimated prevalence of food allergy of 30%. It is estimated that with 15% loss to follow up, there will be 276 high risk children completing the study, 138 in each group. The study has 99% power to detect a reduction from 30% to 10% amongst the high risk participants in the intervention group and 85% to detect a reduction from 30% to 15%. See protocol (Protocol section 9.3: Contract variation September 2010). The study is not powered to detect a reduction in allergy to individual foods. 5. LOSS TO FOLLOW UP 1302 infants will be recruited into the study at three months of age. A drop out figure of 15% has been estimated based on the low rate observed in the LEAP study and in the EAT study at the time of the revised protocol. (Protocol change September 2010). 6. RANDOMIZATION AND BLINDING Participants are randomly assigned to treatment using a centrally administered randomization service (ALEA). The randomization is not stratified given the number of participants. Given the nature of the intervention, the study participants cannot be blinded to their allocation group. However, the study outcomes are based on food challenges that include double-blinded assessment and objective measures of sensitization (skin prick test results) and specific IgE measurements. The latter are measured by laboratory staff blinded to the child s allocation status. 7. ENDPOINTS 7.1 Primary Endpoint The period prevalence of IgE mediated food allergy to the six intervention foods between one and three years of age in both arms. 7.2 Secondary Endpoints Period (one to three years of age) prevalence food outcomes 1. The period prevalence of all IgE mediated food allergy between one and three years of age in both arms. 2. The period prevalence of all reported food allergy (IgE and non-ige mediated) between one and three years of age in both arms. 3. The period prevalence of sensitization to food between one and three years of age in both arms. (Defined in Protocol, Section 3.9). 4. The total number of foods (of the six intervention foods) to which IgE mediated food allergy has been diagnosed between one and three years of age in both arms amongst children with IgE mediated allergy to one or more of the six intervention foods. 5. The total number of foods (any foods) to which IgE mediated food allergy has been diagnosed between one and three years of age in both arms amongst children with IgE mediated allergy to one or more foods Cumulative (by three years of age) prevalence food outcomes 1. The cumulative prevalence of IgE mediated food allergy to the six intervention foods by three years of age. 2. The cumulative prevalence of all IgE mediated food allergy by three years of age. 3. The cumulative prevalence of all food allergy (IgE and non-ige mediated) by three years of age. 4. The cumulative prevalence of non-ige mediated food allergy by three years of age. 5. The cumulative prevalence of sensitization (defined in Section 3.9) to the six foods by three years of age. 6. The total number of foods (of the six intervention foods) to which IgE mediated food allergy has been diagnosed by three years of age amongst children with IgE mediated allergy to one or more of the six intervention foods. 7. The total number of foods (any foods) to which IgE mediated food allergy has been diagnosed by three years of age amongst children with IgE mediated allergy to one or more foods. 2
3 7.2.3 Point prevalence food outcomes 1. The point prevalence of IgE mediated food allergy to the intervention foods (excluding sesame and peanut) at the one year assessment. 2. The point prevalence of IgE mediated food allergy to the intervention foods at the three year assessment Other allergic disease outcomes 1. The point prevalence of eczema at one year and three years of age and cumulative prevalence of eczema by three years of age. 2. The severity of eczema at one year and three years of age. 3. The prevalence of allergic rhinitis at three years of age. 4. The prevalence of inhalant allergen sensitization at one year and at three years of age by skin prick test. 5. The prevalence of inhalant allergen sensitization at one year and at three years of age by specific IgE measurement. 6. The prevalence of the atopic wheeze phenotype at three years of age Composite allergy outcome 1. The prevalence of combined allergic disease (a composite of cumulative IgE mediated food allergy to all foods, atopic wheeze phenotype, eczema and allergic rhinitis) at three years of age. 2. The prevalence of combined allergic disease (a composite of cumulative IgE and non-ige mediated food allergy to all foods, atopic wheeze phenotype, eczema and allergic rhinitis) at three years of age. 7.3 Safety outcomes Adverse events gastrointestinal symptoms For each of these, the number of events will be analysed together with any associated morbidities or treatment as appropriate 1. Diarrhoea 2. Constipation 3. Posseting 4. Vomiting 5. Colic Adverse events atopic symptoms 1. Eczema 2. Wheeze number of episodes, associated shortness of breath, A&E attendances, admissions Adverse events infective symptoms 1. URTI 2. LRTI 3. Bronchiolitis 3
4 4. Other infections Serious adverse events 1. Hospital admissions 2. All serious adverse events Anthropometric outcomes 1. Weight, absolute and SDS at 3, 12 months and three years 2. Length, absolute and SDS, at 3, 12 months and three years 3. BMI, absolute and SDS, at 3, 12 months and three years 4. Head circumference, absolute and SDS, at 3, 12 months and three years 5. Mid upper arm circumference at 3, 12 months and three years 6. Skin fold thickness, subscapular and triceps, at 3, 12 months and three years Behavioural outcomes 1. Sleep outcomes (duration, time to settle, number of wakings) 2. Food aversions outcomes Maternal outcomes 1. Maternal quality of life at 3, 12 months and three years Dietary outcomes 1. Macro nutrient status at 6, 12 months and three years Breastfeeding outcomes 1. Percentage of mothers breastfeeding at 6 months 2. Percentage of SIG mothers exclusively breastfeeding to around six months 3. Total duration of breastfeeding 7. STATISTICAL ANALYSIS Intention to Treat Analysis 4
5 These will be the main analyses and the ones that are used to quantify the efficacy of the intervention. Only ITT results will be reported in the abstracts of the main publication and trial report. All children allocated to each of the two study arms will be analysed together as representing that treatment arm, whether or not they received or completed the prescribed regimen. This will be done after the three year assessment for the period prevalence of IgE mediated food allergy to the six intervention foods between one and three years of age in both arms Per Protocol Analysis These will be reported in the body of the paper after the ITT primary and ITT secondary analyses. They will be included for explanatory purposes only, and will not be reported in the abstract nor regarded as primary or secondary measures of the efficacy of the intervention. Assessing the dose of potentially allergenic food received The following algorithm defines a scoring system that quantifies dose in a relatively simple way and yet allows the detection of a dose-response, albeit outside of the original randomization. Hence for each participant regardless of group, their score will be defined as follows: Each week up to 6 months of age (26 weeks) that a participant ate a particular food at 75% or more would be scored 1 and lesser consumption would be a zero Each food would therefore yield a total score of between 0 and a maximum of 13 (as max weeks=13) The scores will be summed over all foods to give a total food consumption score which will be categorized into quintiles The relationship between score quintiles and the primary outcome will be explored using logistic regression with a test for trend across the quintiles Statistical Methodology Binary outcomes will be presented as proportions and relative risks with 95% confidence intervals, p values being calculated from the chi-square test or Fisher s exact test if numbers are small, with appropriate methods used for the calculation of CIs when numbers are small. Continuous outcomes will be analysed using methods based on the Normal distribution where possible either if data are Normal or can be suitably transformed. Results will be presented as differences in means with 95% confidence intervals and modelled using multiple regression with baseline values as covariates. Adverse events will be reported by treatment group, aggregated and given as number of children, total number of events, and incidence rates per year with 95% confidence intervals Prognostic baseline variables will be inspected for any imbalance between the groups that is judged to be clinically important. If any such imbalance is observed, these variables will be included as covariates in sensitivity analyses for all key outcomes (please see section 8.2 below). All analyses will be 2-sided with 5% significance level. The sections below will outline the analyses for the main paper of the trial and describe what material will be reported in each table. 8.2 Description of baseline data: TABLE 1 5
6 Key variables collected at baseline will be summarised by treatment group. For continuous variables; means and standard deviations will be calculated and for categorical data, actual numbers and the calculated proportions will be shown. No formal testing of baseline characteristics between treatment groups will be performed in keeping with best practice. 1. Sex of infant 2. Birthweight 3. Gestational age 4. Number of siblings 5. Age of mother 6. Maternal education 7. Maternal and paternal asthma/allergy 8. Maternal/paternal smoking 9. Ethnic origin of mother and father 10. Pet ownership status 11. Mode of delivery 12. Allergenic food consumption during pregnancy 13. Allergenic food consumption during lactation pre enrolment 14. Infant eczema status at enrolment 8.3 ANALYSIS OF ENDPOINTS ITT Analysis of Primary Endpoint TABLE 2 The main analysis will compare the period prevalence of IgE mediated food allergy to the six intervention foods between one and three years of age in both arms (protocol, Section 3.3.1). Table 1 will also include allergy to each of the six constituent foods by treatment group. The outcomes to be analysed by intervention group, are listed below: 1. Period prevalence of IgE mediated food allergy to one or more of the six intervention foods between one and three years 2. Period prevalence of IgE mediated food allergy to each of the six intervention foods between one and three years: i. Cow s milk ii. iii. Egg Fish 6
7 iv. Wheat v. Peanut vi. sesame Analysis of Secondary Endpoints by intervention group: TABLES 3-5 The following secondary outcomes will be reported in these tables: TABLE 3: Period and cumulative prevalence (one to three years of age) food outcomes as listed below: 1. The period prevalence of all IgE mediated food allergy between one and three years of age in both arms. 2. The period prevalence of all reported food allergy (IgE and non-ige mediated) between one and three years of age in both arms. 3. The period prevalence of sensitization to food between one and three years of age in both arms (defined in Protocol, Section 3.9). 4. The total number of foods (of the six intervention foods) to which IgE mediated food allergy has been diagnosed between one and three years of age in both arms amongst children with IgE mediated allergy to one or more of the six intervention foods. 5. The total number of foods (any foods) to which IgE mediated food allergy has been diagnosed between one and three years of age in both arms amongst children with IgE mediated allergy to one or more foods. 6. The cumulative prevalence of IgE mediated food allergy to the six intervention foods by three years of age. 7. The cumulative prevalence of all IgE mediated food allergy by three years of age. 8. The cumulative prevalence of all food allergy (IgE and non-ige mediated) by three years of age. 9. The cumulative prevalence of non-ige mediated food allergy by three years of age. 10. The cumulative prevalence of sensitization (defined in Section 3.9) to the six foods by three years of age. 11. The total number of foods (of the six intervention foods) to which IgE mediated food allergy has been diagnosed by three years of age amongst children with IgE mediated allergy to one or more of the six intervention foods. 12. The total number of foods (any foods) to which IgE mediated food allergy has been diagnosed by three years of age amongst children with IgE mediated allergy to one or more foods. TABLE 4: Other allergic diseases and composite allergy outcome by intervention group as listed below: 1. The point prevalence of eczema at one year and three years of age and cumulative prevalence of eczema by three years of age. 2. The severity of eczema at one year and three years of age. 3. The prevalence of allergic rhinitis at three years of age. 4. The prevalence of inhalant allergen sensitization at one year and at three years of age by skin prick test. 5. The prevalence of inhalant allergen sensitization at one year and at three years of age by specific IgE measurement. 6. The prevalence of the atopic wheeze phenotype at three years of age. 7. The prevalence of combined allergic disease (a composite of cumulative IgE mediated food allergy to all foods, atopic wheeze phenotype, eczema and allergic rhinitis) at three years of age. 8. The prevalence of combined allergic disease (a composite of cumulative IgE and non-ige mediated food allergy to all foods, atopic wheeze phenotype, eczema and allergic rhinitis) at three years of age. TABLE 5: Safety outcomes and indicative outcomes as listed below by intervention group: 1. Diarrhoea 2. LRTI 3. Constipation 7
8 4. Eczema 5. Wheeze 6. URTI 7. Bronchiolitis 8. Other infections 9. Hospital admissions 10. Absolute weight at 3, 12 months and three years 11. Weight standard deviation score at 3, 12 months and three years 8.4 MISSING DATA Patterns of missing data will be investigated, in particular looking at whether missingness can be considered to be missing completely at random, missing at random, or missing not at random. Sensitivity analyses assuming different missingness patterns will be undertaken following the general approach of White 2011 (BMJ. 2011; 342: d40; doi: /bmj.d40). 8.5 STATISTICAL PROGRAMS Analysis will be conducted using Stata (version current at the time of analysis). 8
Primary Prevention of Food Allergies
Primary Prevention of Food Allergies Graham Roberts Professor & Honorary Consultant, Paediatric Allergy and Respiratory Medicine, David Hide Asthma and Allergy Research Centre, Isle of Wight & CES & HDH,
More informationPREVENTION OF FOOD ALLERGY. Dr Kate Swan Dr Claire Stockdale
PREVENTION OF FOOD ALLERGY Dr Kate Swan Dr Claire Stockdale Objectives To understand: Food allergy phenotypes The role of the skin barrier in sensitisation Early introduction of food as an allergy prevention
More informationPediatric Food Allergies: Physician and Parent. Robert Anderson MD Rachel Anderson Syracuse, NY March 3, 2018
Pediatric Food Allergies: Physician and Parent Robert Anderson MD Rachel Anderson Syracuse, NY March 3, 2018 Learning Objectives Identify risk factors for food allergies Identify clinical manifestations
More informationFood Allergy A buffet of truths and myths
Food Allergy A buffet of truths and myths Toronto Anaphylaxis Education Group Adelle R. Atkinson M.D. FRCPC Associate Professor of Paediatrics University of Toronto Clinical Immunologist Division of Immunology
More informationGUIDANCE ON THE DIAGNOSIS AND MANAGEMENT OF LACTOSE INTOLERANCE
GUIDANCE ON THE DIAGNOSIS AND MANAGEMENT OF LACTOSE INTOLERANCE These are the lactose intolerance guidelines and it is recommended that they are used in conjunction with the Cow s Milk Allergy guidance.
More informationGP Patient Pathway for Infants under 1 year of age with Cows Milk Protein Allergy (Non IgE Mediated)
GP Patient Pathway for Infants under 1 year of age with Cows Milk Protein Allergy (Non IgE Mediated) Infant suspected with (non IgE) after an allergy focused clinical history has been completed (see appendix
More informationDietary Management of Cow s Milk Protein Allergy
Dietary Management of Cow s Milk Protein Allergy Amy Roberts Paediatric Dietitians September 2014 Objectives To increase confidence in diagnosing a cow s milk allergy To understand the difference between
More informationFOOD ALLERGY IN SOUTH AFRICA Mike Levin
FOOD ALLERGY IN SOUTH AFRICA Mike Levin Michael.levin@uct.ac.za SAFFA: The South African Food sensitisation and Food Allergy study Botha M, Basera W, Gray C, Facey-Thomas H, Levin ME. The Prevalence of
More informationAssociate Professor Rohan Ameratunga
Associate Professor Rohan Ameratunga Adult and Paediatric Clinical Immunologist and Allergist Auckland 9:25-9:45 Preventing Food Allergy Update on Food allergy Associate Professor Rohan Ameratunga Food
More informationGUIDANCE ON THE DIAGNOSIS AND MANAGEMENT OF LACTOSE INTOLERANCE AND PRESCRIPTION OF LOW LACTOSE INFANT FORMULA.
GUIDANCE ON THE DIAGNOSIS AND MANAGEMENT OF LACTOSE INTOLERANCE AND PRESCRIPTION OF LOW LACTOSE INFANT FORMULA. These are the lactose intolerance guidelines and it is recommended that they are used in
More informationPrescribing Guidelines for Lactose Intolerance and Cow s Milk Protein Allergy
Prescribing Guidelines for and Aim To clarify which products and in which circumstances milk substitutes can be prescribed for babies and young children in primary care, as well as to give a guide to prescribing
More informationINFANT FEEDING & ALLERGY PREVENTION
INFANT FEEDING & ALLERGY PREVENTION Sasha Watkins Registered Dietitian Honorary Lecturer UCT, South Africa MA(Cantab), BSc (Hons) Dietetics, MSc (Allergy) SAFFA Study Disclosure In relation to this presentation,
More informationCOW S MILK PROTEIN ALLERGY IN CHILDREN
COW S MILK PROTEIN ALLERGY IN CHILDREN Wednesday 8th June 2016 By Dr Rukhsana Hussain CMPA Cows' milk protein allergy is an immune-mediated allergic response to proteins in milk Milk contains casein and
More informationPreventing food allergy in higher risk infants: guidance for healthcare professionals
Preventing food allergy in higher risk infants: guidance for healthcare professionals This information sheet complements current advice from the Scientific Advisory Committee on Nutrition (SACN) and the
More informationPrescribing Commissioning Policy May Diagnosis and management of Cow s Milk Protein Allergy (CMPA) and Lactose Intolerance
Prescribing Commissioning Policy May 2018 Diagnosis and management of Cow s Milk Protein Allergy (CMPA) and Lactose Intolerance NHS Eastern Cheshire, NHS South Cheshire and NHS Vale Royal Clinical Commissioning
More informationFood Challenges. Exceptional healthcare, personally delivered
Food Challenges Exceptional healthcare, personally delivered Introduction You have been referred to the Immunology department to explore your food allergies. This leaflet provides information on allergies
More informationCow's milk protein allergy (CMPA) suspected
Background information Patient information Key messages for this pathway When to suspect CMPA Symptoms of CMPA and assessing severity Symptoms of non IgE mediated CMPA Severe CMPA: urgent referral to paediatric
More information: Sumadiono, dr SpA(K) Place/date of birth : Nganjuk, : Staff of Pediatric Dept.UGM Yogyakarta
CURRICULUM VITAE Name : Sumadiono, dr SpA(K) Place/date of birth : Nganjuk, 9-10-1956 Occupation : Staff of Pediatric Dept.UGM Yogyakarta Educations : General Doctor : Fac. Of Medicine Unair, Surabaya,
More informationWHY IS THERE CONTROVERSY ABOUT FOOD ALLERGY AND ECZEMA. Food Allergies and Eczema: Facts and Fallacies
Food Allergies and Eczema: Facts and Fallacies Lawrence F. Eichenfield,, M.D. Professor of Clinical Pediatrics and Medicine (Dermatology) University of California, San Diego Rady Children s s Hospital,
More informationprevalence of peanut allergy in children. (J Allergy Clin Immunol 2007;119: )
The impact of government advice to pregnant mothers regarding peanut avoidance on the prevalence of peanut allergy in United Kingdom children at school entry Jonathan O Brien Hourihane, MD, FRCPCH, a,b
More informationLET THEM EAT CAKE DISCLOSURE. Angela Duff Hogan, M.D.
LET THEM EAT CAKE Angela Duff Hogan, M.D. Children s Specialty Group Children s Hospital of the King s Daughters Eastern Virginia Medical School Norfolk, VA DISCLOSURE A. I have no relevant financial relationships
More informationMultiple Imputation for Missing Data in KLoSA
Multiple Imputation for Missing Data in KLoSA Juwon Song Korea University and UCLA Contents 1. Missing Data and Missing Data Mechanisms 2. Imputation 3. Missing Data and Multiple Imputation in Baseline
More informationRandomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants
Original Article Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants Michael R. Perkin, Ph.D., Kirsty Logan, Ph.D., Anna Tseng, R.D., Bunmi Raji, R.D., Salma Ayis, Ph.D., Janet Peacock,
More informationToronto Anaphylaxis Education Group (TAEG) April 5, pm
Toronto Anaphylaxis Education Group (TAEG) April 5, 2016 7-9pm Agenda Introductions Announcements Icebreaker Tonight s program Introductions and Announcements The Toronto Anaphylaxis Education Group (TAEG)
More informationPrevention of peanut allergy in children: understanding the LEAP Study Q&A for the peanut industry
Prevention of peanut allergy in children: understanding the LEAP Study Q&A for the peanut industry What is LEAP? Learning Early about Peanut Allergy (LEAP) is a randomised and controlled five-year clinical
More informationPaediatric Food Allergy and Intolerance. Abigail Macleod, Associate Specialist, RBH
Paediatric Food Allergy and Intolerance Abigail Macleod, Associate Specialist, RBH Ig E mediated food allergy Commonest cause of chronic disease in childhood up to 20% children But treatable, manageable
More informationMedical Conditions Policy
Medical Conditions Policy Background: Anaphylaxis is a severe, life-threatening allergic reaction. Up to two per cent of the general population and up to 5 percent of young children (0-5yrs) are at risk.
More informationCLINICAL AUDIT. Appropriate prescribing of specialised infant formula for cows milk protein allergy
CLINICAL AUDIT Appropriate prescribing of specialised infant formula for cows milk protein allergy Valid to December 2019 bpac nz better medicin e Background Specialised infant formulae subsidised on the
More informationAllergies and Intolerances Policy
Allergies and Intolerances Policy 2016 2018 This policy should be read in conjunction with the following documents: Policy for SEND/Additional Needs Safeguarding & Child Protection Policy Keeping Children
More informationBeth Strong, RN, FNP-C The Jaffe Food Allergy Institute Mount Sinai School of Medicine New York 2/23/13
Beth Strong, RN, FNP-C The Jaffe Food Allergy Institute Mount Sinai School of Medicine New York 2/23/13 I do not have any financial disclosure to report Why Challenge? To confirm that the suspected food
More informationUnderstanding Food Intolerance and Food Allergy
Understanding Food Intolerance and Food Allergy There are several different types of sensitivities or adverse reactions to foods. One type is known as a food intolerance ; an example is lactose intolerance.
More informationResearch Article Growth Parameters Impairment in Patients with Food Allergies
Allergy, Article ID 9873, pages http://dx.doi.org/1.11/214/9873 Research Article Growth Parameters Impairment in Patients with Food Allergies Larissa Carvalho Costa, Erica Rodrigues Rezende, and Gesmar
More informationMissing value imputation in SAS: an intro to Proc MI and MIANALYZE
Victoria SAS Users Group November 26, 2013 Missing value imputation in SAS: an intro to Proc MI and MIANALYZE Sylvain Tremblay SAS Canada Education Copyright 2010 SAS Institute Inc. All rights reserved.
More information1 in 5. In Singapore, allergies like atopic dermatitis (eczema) now affect around. Read on to find out more about allergies.
In Singapore, allergies like atopic dermatitis (eczema) now affect around 1 in 5 1 Read on to find out more about allergies. Reviewed by Reference: 1. Tan T, et al. Prevalence of allergy-related symptoms
More informationAre we any closer to understanding the rise in food allergy?
ILSI SEAR A Asia Maternal & Infant Nutrition Australia, August 2014 (www.ilsi.org/sea_region) Professor Katie Allen Are we any closer to understanding the rise in food allergy? Hospital admissions for
More informationEmerging Local Food Systems in the Caribbean and Southern USA July 6, 2014
Consumers attitudes toward consumption of two different types of juice beverages based on country of origin (local vs. imported) Presented at Emerging Local Food Systems in the Caribbean and Southern USA
More informationAPPROACH TO FOOD ALLERGY IN CHILDREN WHY TALK ABOUT FOOD ALLERGY? DISEASES BLAMED ON FOOD ALLERGY ADVERSE REACTIONS TO FOOD OVERVIEW
APPROACH TO FOOD ALLERGY IN CHILDREN DR MEERA THALAYASINGAM INTERNATIONAL MEDICAL UNIVERSITY RAMSAY SIME DARBY HEALTHCARE MALAYSIA APAPARI WORKSHOP PHNOM PENH CAMBODIA_ 12 TH SEPT 2015 WHY TALK ABOUT FOOD
More informationMelbourne University Sport Anaphylaxis Policy
Melbourne University Sport Anaphylaxis Policy The safety and well-being of children is of prime importance at Melbourne University Sport Programs. All reasonable steps will be taken to ensure the safety
More informationRandomized controlled trial of early regular egg intake to prevent egg allergy
Randomized controlled trial of early regular egg intake to prevent egg allergy Debra J. Palmer, PhD, a,b Thomas R. Sullivan, BMa&CompSc(Hons), c Michael S. Gold, MD, d Susan L. Prescott, MD, PhD, a,e and
More informationUsing the Milk Ladder to re-introduce milk and dairy
Paediatric Unit information for parents and carers Using the Ladder to re-introduce milk and dairy This leaflet explains what the Ladder is and how to use it. What is the Ladder? The Ladder is an evidence-based
More informationCOMPARISON OF EMPLOYMENT PROBLEMS OF URBANIZATION IN DISTRICT HEADQUARTERS OF HYDERABAD KARNATAKA REGION A CROSS SECTIONAL STUDY
I.J.S.N., VOL. 4(2) 2013: 288-293 ISSN 2229 6441 COMPARISON OF EMPLOYMENT PROBLEMS OF URBANIZATION IN DISTRICT HEADQUARTERS OF HYDERABAD KARNATAKA REGION A CROSS SECTIONAL STUDY 1 Wali, K.S. & 2 Mujawar,
More informationPARENTAL SCHOOL CHOICE AND ECONOMIC GROWTH IN NORTH CAROLINA
PARENTAL SCHOOL CHOICE AND ECONOMIC GROWTH IN NORTH CAROLINA DR. NATHAN GRAY ASSISTANT PROFESSOR BUSINESS AND PUBLIC POLICY YOUNG HARRIS COLLEGE YOUNG HARRIS, GEORGIA Common claims. What is missing? What
More informationGluten Sensitivity Fact from Myth. Disclosures OBJECTIVES 18/09/2013. Justine Turner MD PhD University of Alberta. None Relevant
Gluten Sensitivity Fact from Myth Justine Turner MD PhD University of Alberta Disclosures None Relevant OBJECTIVES Understand the spectrum of gluten disorders Develop a diagnostic algorithm for gluten
More informationSYLLABUS. Departmental Syllabus. Food Production II CULN0140. Departmental Syllabus. Departmental Syllabus. Departmental Syllabus
DATE OF LAST REVIEW: 02/2013 CIP CODE: 12.0505 SYLLABUS SEMESTER: COURSE TITLE: COURSE NUMBER: Food Production II CULN0140 CREDIT HOURS: 4 INSTRUCTOR: OFFICE LOCATION: OFFICE HOURS: TELEPHONE: EMAIL: KCKCC
More informationFood Allergies on the Rise in American Children
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/hot-topics-in-allergy/food-allergies-on-the-rise-in-americanchildren/3832/
More information'Every time I eat dairy foods I become ill, could I have a milk allergy.? '. Factors involved in the development of cow's milk allergy:
'Every time I eat dairy foods I become ill, could I have a milk allergy.? '. Dairy allergy is relatively common in the community. The unpleasant symptoms some people experience after eating dairy foods
More informationFungicides for phoma control in winter oilseed rape
October 2016 Fungicides for phoma control in winter oilseed rape Summary of AHDB Cereals & Oilseeds fungicide project 2010-2014 (RD-2007-3457) and 2015-2016 (214-0006) While the Agriculture and Horticulture
More informationViaskin Peanut Highlights. Press Release Montrouge, France, March 5, 2017
Press Release Montrouge, France, March 5, 2017 Data at AAAAI 2017 Show Lasting Response and Favorable Safety Profile of Investigational Agent, Viaskin Peanut, Throughout Three Years of Treatment of Peanut
More informationDiagnosis and assessment of food allergy in children and young people in primary care and community settings
Diagnosis and assessment of food allergy in children and young people in primary care and community settings Full guideline November 2010 This guideline was developed following the NICE short clinical
More informationDEVELOPMENT AND STANDARDISATION OF FORMULATED BAKED PRODUCTS USING MILLETS
IMPACT: International Journal of Research in Applied, Natural and Social Sciences (IMPACT: IJRANSS) ISSN(E): 2321-8851; ISSN(P): 2347-4580 Vol. 2, Issue 9, Sep 2014, 75-78 Impact Journals DEVELOPMENT AND
More informationFood Allergies Among Children -
Food Allergies Among Children - Growth, Treatment, Prevention and a Challenge for the Food Industry Steve L. Taylor, Ph.D. Food Allergy Research & Resource Program University of Nebraska Food Navigator
More informationCorporate Presentation. October 2018
Corporate Presentation October 2018 Forward-Looking Statements This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995 regarding, among
More informationImproving allergy outcomes. IgE and IgG 4 food serology in a Gastroenterology Practice. Jay Weiss, Ph.D and Gary Kitos, Ph.D., H.C.L.D.
Improving allergy outcomes IgE and IgG 4 food serology in a Gastroenterology Practice Jay Weiss, Ph.D and Gary Kitos, Ph.D., H.C.L.D. IgE and IgG4 food serology in a gastroenterology practice The following
More informationGail E. Potter, Timo Smieszek, and Kerstin Sailer. April 24, 2015
Supplementary Material to Modelling workplace contact networks: the effects of organizational structure, architecture, and reporting errors on epidemic predictions, published in Network Science Gail E.
More informationClinical Manifestations and Management of Food Allergy
Clinical Manifestations and Management of Food Allergy Adrian Sie Consultant in paediatrics, Wishaw General, Lanarkshire April 2013 To do Bring Allergy plan Prevention photo Contents Is it allergy? How
More informationREVISED 04/10/2018 Page 1 of 7 FOOD ALLERGY MANAGEMENT PLAN
GARLAND INDEPENDENT SCHOOL DISTRICT HEALTH SERVICES Food Allergy Management Plan DEFINITIONS FOOD INTOLERANCE ALLERGIC REACTION SEVERE FOOD ALLERGY ANAPHYLACTIC REACTION FOOD ALLERGY MANAGEMENT PLAN (FAMP)
More informationProblem Set #3 Key. Forecasting
Problem Set #3 Key Sonoma State University Business 581E Dr. Cuellar The data set bus581e_ps3.dta is a Stata data set containing annual sales (cases) and revenue from December 18, 2004 to April 2 2011.
More informationFurther investigations into the rind lesion problems experienced with the Pinkerton cultivar
Further investigations into the rind lesion problems experienced with the Pinkerton cultivar FJ Kruger and SD Mhlophe Agricultural Research Council Institute for Tropical and Subtropical Crops Private
More informationPOLICY: ANAPHYLAXIS MANAGEMENT
1. STATEMENT OF BELIEF: Drouin Secondary College believes that the safety and wellbeing of children who are at risk of anaphylaxis is a whole-of-community responsibility. We are committed to: providing,
More informationAll About Allergies. Chirag Akella 8th grade Mrs. Goldsworthy Jordan Middle School, Palo Alto 2013
All About Allergies Chirag Akella 8th grade Mrs. Goldsworthy Jordan Middle School, Palo Alto 2013 Allergy and Asthma Fundamentals Allergy [al-er-jee] An abnormal reaction of the body to a previously encountered
More informationFood Allergy Prevention (Peanuts) Gideon Lack
Food Allergy Prevention (Peanuts) Gideon Lack Conflict of Interest Scientific advisory board to DBV Technologies and shareholder National Peanut Board support for other studies Overview 1. Background &
More informationAnaphylaxis Management in the School Setting
Anaphylaxis Management in the School Setting Keeping Children Safe Anita Wheeler, RN, MSN School Health Coordinator/Nurse Consultant anita.wheeler@dshs.state.tx.us 1 Learning Objectives The learner will
More informationThe impact of a continuous care intervention for treatment of type 2 diabetes on health care system utilization
The impact of a continuous care intervention for treatment of type 2 diabetes on health care system utilization Zachary Wagner, Nasir H. Bhanpuri, James P. McCarter, Neeraj Sood [Supplementary Appendix]
More informationReport No. 3 of the Health and Emergency Medical Services Committee Regional Council Meeting of April 27, SABRINA'S LAW
1 SABRINA'S LAW The Health and Emergency Medical Services Committee recommends the adoption of the recommendation contained in the following report, March 9, 2006, from the Commissioner of Community Services,
More informationAllergy and Anaphylaxis Policy
Statement This policy serves to promote an allergy aware community. At Splash Centre we have recognised the need to adopt a policy on allergies that may be present in the children who attend our centre.
More informationA review of recent literature published in 2008 related to the timing of the introduction of solids Diana Langton IBCLC FCHN B.Health ScienceRM,RN
Concerns and Controversies A review of recent literature published in 2008 related to the timing of the introduction of solids Diana Langton IBCLC FCHN B.Health ScienceRM,RN WHO Recommendation 2001 Recommended
More informationAccording to a post-hoc analysis, 62.6% of patients receiving Viaskin Peanut showed an increase in their eliciting dose at 12 months of treatment
Montrouge, France, February 22, 2019 DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American
More informationThe speaker had sole editorial control over the content in this slide deck.
Paediatric Gastro-Allergy Symposium The speaker had sole editorial control over the content in this slide deck. Any views, opinions or recommendations expressed in the slides are solely those of the speaker
More informationFood Allergen Labeling and Consumer Protection Act of 2004
FDA Home Page CFSAN Home Search/Subject Index Q & A Help August 2, 2004 Food Allergen Labeling and Consumer Protection Act of 2004 (Title II of Public Law 108-282) (This document also available in PDF)
More informationProblem. Background & Significance 6/29/ _3_88B 1 CHD KNOWLEDGE & RISK FACTORS AMONG FILIPINO-AMERICANS CONNECTED TO PRIMARY CARE SERVICES
CHD KNOWLEDGE & RISK FACTORS AMONG FILIPINO-AMERICANS CONNECTED TO PRIMARY CARE SERVICES Background & Significance Who are the Filipino- Americans? Alona D. Angosta, PhD, APN, FNP, NP-C Assistant Professor
More informationEVIDENCE CLIP. Food Allergy Prevention in Infants. Topic Overview. Current Guidelines. April 2016 ZZZZZZZZZZZZZZZZZ
EVIDENCE CLIP Food Allergy Prevention in Infants April 2016 ZZZZZZZZZZZZZZZZZ Topic Overview Current Guidelines Concerns about food allergies are common in North America and other western countries. The
More informationTesting for food allergy in children and young people
Issue date: February 2011 Understanding NICE guidance Information for people who use NHS services Testing for food allergy in children and young people NICE clinical guidelines advise the NHS on caring
More informationBroadmeadows Valley Primary School ANAPHYLAXIS MANAGEMENT POLICY
Broadmeadows Valley Primary School ANAPHYLAXIS MANAGEMENT POLICY RATIONALE: Anaphylaxis is a severe, rapidly progressive allergic reaction, that is potentially life threatening. The most common allergens
More informationPower and Priorities: Gender, Caste, and Household Bargaining in India
Power and Priorities: Gender, Caste, and Household Bargaining in India Nancy Luke Associate Professor Department of Sociology and Population Studies and Training Center Brown University Nancy_Luke@brown.edu
More informationAngel Rebollar-Alvitar and Michael A. Ellis The Ohio State University/OARDC Department of Plant Pathology 1680 Madison Avenue Wooster, OH 44691
Evaluation of strobilurin fungicides (Abound and Cabrio), potassium phosphite ( ProPhyt ) and Ridomil Gold for control of leather rot of strawberry, caused by Phytophthora cactorum. Angel Rebollar-Alvitar
More informationDietary management of food allergy & intolerance
Dietary management of food allergy & intolerance Dr Emilia Vassilopoulou BsC, PhD, Post-Doc Clinical Nutritionist Dietitian Food Allergy An adverse immune response to a food protein Reactions to a food
More informationObjectives. 1 st half: 2 nd half:
Ask the Allergist Edmond S. Chan, MD, FRCPC Clinical Associate Professor, UBC Division of Allergy & Immunology June 14, 2014 Metro Vancouver Anaphylaxis Group Burnaby Objectives 1 st half: Discuss: How
More informationTHE ECONOMIC IMPACT OF BEER TOURISM IN KENT COUNTY, MICHIGAN
THE ECONOMIC IMPACT OF BEER TOURISM IN KENT COUNTY, MICHIGAN Dan Giedeman, Ph.D., Paul Isely, Ph.D., and Gerry Simons, Ph.D. 10/8/2015 THE ECONOMIC IMPACT OF BEER TOURISM IN KENT COUNTY, MICHIGAN EXECUTIVE
More informationILSI Workshop on Food Allergy: From Thresholds to Action Levels. The Regulators perspective
ILSI Workshop on Food Allergy: From Thresholds to Action Levels The Regulators perspective 13-14 September 2012 Reading, UK Sue Hattersley UK Food Standards Agency Public health approach Overview Guidance
More informationREGULATORS PERSPECTIVE ON ALLERGEN MANAGEMENT IN THE FOOD INDUSTRY
REGULATORS PERSPECTIVE ON ALLERGEN MANAGEMENT IN THE FOOD INDUSTRY IFST CONFERENCE, CAMPDEN BRI 7-8 APRIL 2011 Sue Hattersley Head of Food Allergy Branch UK Food Standards Agency Overview Background on
More informationGuidance On Prescribing Cow's Milk Free Formulae To Treat Cow's Milk Protein Allergy In Infants And Children. Uncontrolled when printed.
NHS Grampian Guidance On Prescribing Cow's Milk Free Formulae To Treat Cow's Milk Protein Allergy In Infants And Children Co-ordinators: Consultation Group: Approver: Dietetic Prescribing NHS Grampian
More informationFrontiers in Food Allergy and Allergen Risk Assessment and Management. 19 April 2018, Madrid
Frontiers in Food Allergy and Allergen Risk Assessment and Management 19 April 2018, Madrid Food allergy is becoming one of the serious problems of China's food safety and public health emergency. 7 Number
More informationCitation for published version (APA): Goossens, N. (2014). Health-Related Quality of Life in Food Allergic Patients: Beyond Borders [S.l.]: s.n.
University of Groningen Health-Related Quality of Life in Food Allergic Patients Goossens, Nicole IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite
More informationAllergy Management Policy
Allergy Management Policy Awareness in the Classrooms All Saints Catholic School 48735 Warren Road Canton, MI 48187 734-459-2490 Information and Guidelines For School and Parents All Saints Catholic School
More informationLevel 2 Mathematics and Statistics, 2016
91267 912670 2SUPERVISOR S Level 2 Mathematics and Statistics, 2016 91267 Apply probability methods in solving problems 9.30 a.m. Thursday 24 November 2016 Credits: Four Achievement Achievement with Merit
More informationSYLLABUS. Departmental Syllabus. Food Production I CULN0130. Departmental Syllabus. Departmental Syllabus. Departmental Syllabus
DATE OF LAST REVIEW: 02/2013 CIP CODE: 12.0505 SYLLABUS SEMESTER: COURSE TITLE: COURSE NUMBER: Food Production I CULN0130 CREDIT HOURS: 4 INSTRUCTOR: OFFICE LOCATION: OFFICE HOURS: TELEPHONE: EMAIL: PREREQUISITES:
More informationNot elevated 71. Elevated 14. Highly elevated out of 90 tested allergens were elevated or highly elevated
Sample ID: Test101 Dear Your Name, This ImuPro laboratory report contains your personalized food allergy test results and recommendations for your path to wellness. Your blood has been analyzed for the
More informationImuPro shows you the way to the right food for you. And your path for better health.
Your personal ImuPro Screen + documents Sample ID: 33333 Dear, With this letter, you will receive the ImuPro result for your personal IgG food allergy test. This laboratory report contains your results
More informationFPIES ANOTHER DISEASE ABOUT WHICH YOU SHOULD KNOW OBJECTIVES FPIES FPIES 11/10/2016. What is that? Robert P. Dillard, M.D.
ANOTHER DISEASE ABOUT WHICH YOU SHOULD KNOW What is that? Robert P. Dillard, M.D. Food Protein Induced Enterocolitis Syndrome. OBJECTIVES 1: Awareness of this syndrome 2: Characteristics 3: Diagnosis 4:
More informationHow to avoid complete elimination
How to avoid complete elimination Yu Okada 1, 2), Noriyuki Yanagida 2), Sakura Sato 2), Motohiro Ebisawa 2) 1) Department of Family Physician, Kameda Family Clinic Tateyama, Chiba, Japan 2) Department
More informationa) all students and staff with a life threatening allergy (anaphylaxis) are entitled to safe and healthy learning and working environments.
Title: ANAPHYLACTIC REACTIONS Adopted: December 1, 2015 Reviewed: February 2018 Revised: Authorization: Sabrina s Law POLICY It is the policy of the Bloorview School Authority that: a) all students and
More informationNon-Allergenic Egg Substitutes in Muffins
Non-Allergenic Egg Substitutes in Muffins ABSTRACT Most egg substitutes on the market are those derived from egg products. While these are acceptable for consumers merely wanting to avoid the cholesterol
More informationPeanut and Tree Nut allergy
Peanut and Tree Nut allergy What are peanuts & tree nuts? Peanuts are also called ground nuts, monkey nuts, beer nuts, earth nuts, goober peas, mendelonas and arachis Tree nuts include almond, Brazil,
More informationCan You Tell the Difference? A Study on the Preference of Bottled Water. [Anonymous Name 1], [Anonymous Name 2]
Can You Tell the Difference? A Study on the Preference of Bottled Water [Anonymous Name 1], [Anonymous Name 2] Abstract Our study aims to discover if people will rate the taste of bottled water differently
More informationFOOD ALLERGY Recent Research- UPDATE פרופ' יצחק כץ
FOOD ALLERGY Recent Research- UPDATE פרופ' יצחק כץ הפקולטה לרפואת ילדים, אביב. בית הספר לרפואה ע"ש סאקלר אוניברסיטת תל- 11/20/2016 ISRAELPEDIATRIC SOCEITY - NOV 2016 ALLERGYSITE@GMAIL.COM 1 Hippocrates
More informationImproving the quality of life of families affected by food allergy: a psychological perspective
Improving the quality of life of families affected by food allergy: a psychological perspective Dr Rebecca Knibb Aston Research Centre for Child and Young People s Health Aston University, U.K. r.knibb@aston.ac.uk
More informationFood Allergies. In the School Setting
Food Allergies In the School Setting Food Allergy Basics Food Allergy Basics The role of the immune system is to protect the body from germs and disease A food allergy is an abnormal response by the immune
More informationRELATIVE EFFICIENCY OF ESTIMATES BASED ON PERCENTAGES OF MISSINGNESS USING THREE IMPUTATION NUMBERS IN MULTIPLE IMPUTATION ANALYSIS ABSTRACT
RELATIVE EFFICIENCY OF ESTIMATES BASED ON PERCENTAGES OF MISSINGNESS USING THREE IMPUTATION NUMBERS IN MULTIPLE IMPUTATION ANALYSIS Nwakuya, M. T. (Ph.D) Department of Mathematics/Statistics University
More informationImputation Procedures for Missing Data in Clinical Research
Imputation Procedures for Missing Data in Clinical Research Appendix B Overview The MATRICS Consensus Cognitive Battery (MCCB), building on the foundation of the Measurement and Treatment Research to Improve
More informationPEEL RIVER HEALTH ASSESSMENT
PEEL RIVER HEALTH ASSESSMENT CONTENTS SUMMARY... 2 Overall River Health Scoring... 2 Overall Data Sufficiency Scoring... 2 HYDROLOGY... 3 Overall Hydrology River Health Scoring... 3 Hydrology Data Sufficiency...
More information